z-logo
open-access-imgOpen Access
Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
Author(s) -
Inès Dufait,
Thérèse Liechtenstein,
Alessio Lanna,
Christopher Bricogne,
Roberta Laranga,
Antonella Padella,
Karine Breckpot,
David Escors
Publication year - 2012
Publication title -
scientifica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.474
H-Index - 21
ISSN - 2090-908X
DOI - 10.6064/2012/694137
Subject(s) - viral vector , transgene , biology , genetic enhancement , transduction (biophysics) , immune system , gene delivery , immune tolerance , microbiology and biotechnology , virology , gene , computational biology , immunology , genetics , recombinant dna , biochemistry
Retroviral and lentiviral vectors have proven to be particularly efficient systems to deliver genes of interest into target cells, either in vivo or in cell cultures. They have been used for some time for gene therapy and the development of gene vaccines. Recently retroviral and lentiviral vectors have been used to generate tolerogenic dendritic cells, key professional antigen presenting cells that regulate immune responses. Thus, three main approaches have been undertaken to induce immunological tolerance; delivery of potent immunosuppressive cytokines and other molecules, modification of intracellular signalling pathways in dendritic cells, and de-targeting transgene expression from dendritic cells using microRNA technology. In this review we briefly describe retroviral and lentiviral vector biology, and their application to induce immunological tolerance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom